Source: Biochemical Pharmacology. Unidades: FMRP, FCFRP
Subjects: HIPERTROFIA VENTRICULAR ESQUERDA, ANTIBIÓTICOS, REGULAÇÃO GÊNICA, HIPERTENSÃO, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARENTE, Juliana Montenegro et al. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin. Biochemical Pharmacology, v. 193, p. 1-13, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2021.114744. Acesso em: 01 nov. 2024.APA
Parente, J. M., Mello, M. M. B. de, Silva, P. H. L. da, Omoto, A. C. M., Pernomian, L., Oliveira, I. S. de, et al. (2021). MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin. Biochemical Pharmacology, 193, 1-13. doi:10.1016/j.bcp.2021.114744NLM
Parente JM, Mello MMB de, Silva PHL da, Omoto ACM, Pernomian L, Oliveira IS de, Mahmud Z, Júnior RF, Arantes EC, Schulz R, Castro MM de. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin [Internet]. Biochemical Pharmacology. 2021 ; 193 1-13.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.bcp.2021.114744Vancouver
Parente JM, Mello MMB de, Silva PHL da, Omoto ACM, Pernomian L, Oliveira IS de, Mahmud Z, Júnior RF, Arantes EC, Schulz R, Castro MM de. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin [Internet]. Biochemical Pharmacology. 2021 ; 193 1-13.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.bcp.2021.114744